Avian flu vaccine
- Experimental Vaccine Protects Against 1918 Flu. // Drug Discovery & Development;Nov2006, Vol. 9 Issue 11, p10
The article reports on the vaccine that protects mice against the killer 1918 influenza virus developed by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases in the U.S. The scientists created a practical method to identify antibodies that...
- NIAID Study Finds Higher Dose of Influenza Vaccine Improves Immune Response in the Elderly. // Ethnicity & Disease;Autumn2006, Vol. 16 Issue 4, p1008
The article highlights a clinical trial supported by the United States National Institute of Allergy and Infectious Diseases (NIAID) which suggests that a higher dose of seasonal influenza vaccine may provide elderly Americans with extra protection against the annual influenza virus. According...
- US Government Orders 2M Doses of Avian Flu Vaccine. Chiarello, Kaylynn // Pharmaceutical Technology;Sep2005, Vol. 29 Issue 9, p23
Reports on the plan of the U.S. National Institute of Allergy and Infectious Diseases (NIAID) to order two million doses of an avian influenza vaccine from pharmaceutical firm, Sanofi Pasteur. Effort of NIAID to evaluate the vaccine's safety and ability to generate immunity against H5N1 strain...
- Vaccinating Kids Could Slow Flu Evolution. // BioWorld Today;11/2/2009, Vol. 20 Issue 211, p5
The article reports on the conclusion of a study by the National Institute of Allergy and Infectious Diseases in the U.S. that changes in the flu virus may be slowed down by administering vaccines to more children. It is noted that flu viruses change forms in order to evade antibodies. It also...
- FDA Licenses Sanofi-Pasteur's H5N1 Vaccine. Rios, Maribel // Pharmaceutical Technology;Jun2007, Vol. 31 Issue 6, p26
The article discusses the licensing of Sanofi-Pasteur H5N1 vaccine by the U.S. Food and Drug Administration (FDA). The H5N1 is the first avian-influenza vaccine for humans that has been approved and become a part of the vaccine-stockpile program of the government. The licensure is based on the...
- New flu vaccine produces fewer minor side effects. // Professional Safety;Aug95, Vol. 40 Issue 8, p12
Reports on the results of a study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) which developed a genetically engineered influenza vaccine which protects against infection and has fewer side effects than other vaccines. Contact information.
- New generation flu shot. // Presidents & Prime Ministers;Nov/Dec95, Vol. 4 Issue 5, p38
Reports on the results of a preliminary study sponsored by the US National Institute of Allergy and Infectious Diseases on the ability of a genetically engineered influenza vaccine to protect people from influenza. Tolerance and immunogenicity of the vaccine.
- Spray relief... // FDA Consumer;Sep/Oct98, Vol. 32 Issue 5, p6
Reports on the findings of researchers at the United States National Institute of Allergy and Infectious Diseases, that the vaccine FluMist seems highly effective in the prevention of the flu and flu-related ear infections. Statistical information representing the research findings.
- Vaccines shoot for more precise population targets. Katsnelson, Alla // Nature Medicine;Apr2012, Vol. 18 Issue 4, p478
The article focuses on a study by researcher Marina Ulanova and colleagues of Northern Ontario School of Medicine in Thunder Bay concerning the impact of vaccination in Haemophilus influenza. It says that the team has announced its plan in February 2012 to gather blood samples from the residents...